Market Overview
The global anti-snoring devices market is poised for steady growth, supported by rising awareness of sleep health and the growing prevalence of sleep-disordered breathing conditions such as obstructive sleep apnea (OSA). In 2025, the market size is projected to reach US$1.6 billion, with further expansion expected to push it to US$2.6 billion by 2032, reflecting a compound annual growth rate (CAGR) of 8.2% during the forecast period.
Key growth drivers include the increasing global incidence of habitual snoring and OSA, greater recognition of the health risks linked to untreated snoring—such as cardiovascular disease and chronic fatigue—and rising demand for non-invasive treatment options. Advancements in mandibular advancement devices (MADs), nasal dilators, CPAP machines, and smart wearable technologies are also fueling adoption by enhancing patient comfort, treatment effectiveness, and compliance.
Among product types, mandibular advancement devices dominate the market and are projected to capture 42.3% of the share in 2025 due to their effectiveness, accessibility, and high clinical acceptance. From a geographical standpoint, North America leads the market with a 39.5% share in 2025, supported by strong diagnostic infrastructure, widespread awareness, and high prevalence of OSA and chronic snoring. Meanwhile, Asia Pacific is set to be the fastest-growing region, driven by expanding healthcare access, rising disposable incomes, and growing recognition of sleep disorders.
Key Highlights from the Report
• Global anti-snoring devices market projected to grow from US$1.6 Bn in 2025 to US$2.6 Bn by 2032.
• North America to remain the leading region with a 39.5% market share in 2025.
• Asia Pacific anticipated as the fastest-growing region during the forecast period.
• Mandibular advancement devices (MADs) to dominate with 42.3% market share in 2025.
• Online distribution channels projected to capture 47.1% of the market in 2025.
• Technological innovations in smart wearables to enhance comfort, detection, and compliance.
𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝐔𝐬𝐞 𝐂𝐨𝐫𝐩𝐨𝐫𝐚𝐭𝐞 𝐄𝐦𝐚𝐢𝐥 𝐈𝐃 𝐟𝐨𝐫 𝐚 𝐐𝐮𝐢𝐜𝐤 𝐑𝐞𝐬𝐩𝐨𝐧𝐬𝐞): https://www.persistencemarketresearch.com/samples/35318
Market Segmentation
The anti-snoring devices market is segmented based on product type, distribution channel, and end-user.
By product type, mandibular advancement devices (MADs) dominate the market. MADs are widely prescribed for patients with mild to moderate obstructive sleep apnea or habitual snoring, especially for those unable to tolerate CPAP therapy. Their non-invasive design, portability, and higher adherence rates compared to CPAP machines make them the preferred first-line option. Other segments, such as tongue-retaining devices (TRDs), nasal dilators, and chin straps, continue to serve niche markets, while CPAP therapy remains critical for moderate-to-severe OSA patients.
By distribution channel, online platforms are emerging as the most significant channel, expected to capture 47.1% of the global share in 2025. The shift reflects growing consumer preference for discreet purchasing, competitive pricing, and wide product availability through e-commerce. Specialty clinics, dental practices, and offline retail stores also play a significant role, particularly for patients requiring custom-fitted or prescription devices.
By end-user, homecare settings dominate due to the preference for self-administered, non-invasive solutions that can be purchased online or through pharmacies. Healthcare institutions, including hospitals and sleep clinics, continue to play a key role in initial diagnosis, prescription, and advanced therapy deployment, especially for CPAP and surgical interventions.
Regional Insights
North America
North America leads the global anti-snoring devices market, holding nearly 39.5% of the share in 2025. High prevalence rates of OSA and habitual snoring, coupled with strong diagnostic capabilities and reimbursement support, fuel demand for devices. In the U.S. alone, over 39 million adults suffer from sleep apnea, while nearly half of the adult population reports snoring. Advanced healthcare infrastructure, early adoption of digital health technologies, and robust distribution networks position the region as a mature and lucrative market.
Europe
Europe is projected to account for approximately 27.7% of the global market in 2025, with high prevalence of sleep-disordered breathing across the continent. Countries such as France, Germany, and the U.K. report significant burdens of OSA and habitual snoring, particularly among aging and overweight populations. Growing clinical awareness, expanded diagnostic coverage, and the adoption of custom-fitted oral appliances are propelling demand. Despite widespread awareness, treatment gaps remain, presenting opportunities for broader adoption of anti-snoring solutions.
Asia Pacific
Asia Pacific is set to be the fastest-growing region over the forecast period, fueled by rapid urbanization, rising disposable incomes, and growing awareness of sleep-related disorders. In countries such as India and China, up to 20% of adults are estimated to suffer from moderate-to-severe OSA, yet diagnosis and treatment rates remain comparatively low. Expanding healthcare infrastructure, increased e-commerce penetration, and rising public health campaigns are expected to accelerate device adoption in the coming years.
Market Drivers
The primary driver of the anti-snoring devices market is the rising prevalence of obstructive sleep apnea and habitual snoring. According to the World Sleep Society, an estimated 936 million adults globally are affected by OSA, with nearly half of cases classified as moderate to severe. Untreated OSA and chronic snoring are strongly associated with hypertension, heart disease, diabetes, and cognitive decline, increasing the urgency for effective solutions. Growing awareness campaigns, combined with clinical recommendations for early intervention, are spurring device adoption.
Technological innovation is another critical growth driver. Advances in mandibular advancement devices, nasal dilators, and CPAP machines—along with the introduction of smart wearable solutions—have significantly enhanced patient experience, compliance, and effectiveness. Integration with mobile health applications and AI-driven monitoring is further aligning these devices with evolving consumer health habits.
Market Restraints
Despite strong demand, the market faces constraints, primarily due to low patient compliance and discomfort associated with certain devices. Studies indicate that nearly 30–50% of CPAP users discontinue therapy within the first year, citing issues such as nasal dryness, leakage, or discomfort from the mask. Oral appliances, including MADs and TRDs, are associated with side effects such as jaw discomfort, dental misalignment, or excessive salivation, which discourage long-term use. These challenges undermine the effectiveness of otherwise clinically proven solutions, creating barriers to sustained adoption.
Market Opportunities
Opportunities for the anti-snoring devices market lie in technological advancements and smart wearables. Increasing use of consumer sleep-tracking tools, including smartwatches and mobile apps, is fostering demand for integrated solutions that detect snoring and apnea events with high accuracy. Innovations such as fabric-based sensors in sleepwear, smart oral appliances, and AI-powered monitoring represent new growth frontiers. Additionally, the expansion of e-commerce platforms enables broader reach, especially in emerging economies where awareness and healthcare access are on the rise. Companies focusing on affordability, personalization, and digital integration are well-positioned to capitalize on these trends.
Reasons to Buy the Report
• Gain detailed insights into market size, growth drivers, and forecasts through 2032.
• Understand regional dynamics and identify high-growth opportunities in key geographies.
• Evaluate product-type trends and competitive positioning across market segments.
• Stay informed on technological innovations shaping the future of anti-snoring devices.
• Benchmark key players and their strategic developments to support decision-making.
Frequently Asked Questions (FAQs)
- How Big is the Anti-Snoring Devices Market?
- Who are the Key Players in the Global Anti-Snoring Devices Market?
- What is the Projected Growth Rate of the Market from 2025 to 2032?
- What is the Market Forecast for Anti-Snoring Devices by 2032?
- Which Region is Estimated to Dominate the Industry through the Forecast Period?
Company Insights
• ResMed
• SomnoMed
• ProSomnus Sleep Technologies
• Vivos Therapeutics, Inc.
• Koninklijke Philips N.V.
• DynaFlex
• Fisher & Paykel Healthcare Limited
• Apnea Sciences Corporation
• MPowrx Health and Wellness Products
• MEDiTAS Ltd.
• The Pure Sleep Company
• Tomed GmbH
• ZQuiet
• Zeus Sleep
• Smart Nora
• Panthera Sleep
• The Sleep Doctor
• VitalSleep
• Good Morning Snore Solution
• SleepTight
Recent Developments
In January 2025, ResMed launched a new device for managing obstructive sleep apnea in India, designed to improve adherence and ease of use for patients.
In December 2024, ZQuiet introduced the ZQuiet Advance, an adjustable, lightweight mouthpiece featuring moldable trays for custom comfort and enhanced jaw advancement.
Conclusion
The global anti-snoring devices market is expanding at a steady pace, supported by rising awareness of sleep health, growing prevalence of sleep-disordered breathing, and technological innovations in oral appliances, nasal dilators, and smart wearable technologies. With the market projected to grow from US$1.6 billion in 2025 to US$2.6 billion by 2032, the outlook remains promising for both established players and emerging innovators. North America will maintain its lead, while Asia Pacific will experience the fastest growth, driven by improving access and digital adoption. Companies that prioritize comfort, affordability, and digital integration are expected to thrive in the evolving landscape of sleep health solutions.
𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬:
